Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to plozasiran for use as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome ...

Second study reveals prevalence of 8.7% for elevated BP, 5.4% for hypertension among youth aged 8 to 19 years.

In a statement, the ERISA Industry Committee, which represents major employers, warned that some of the rules are "so burdensome that many of our members will have no other choice but to re-think the ...

HealthDay News — A case of bird flu has been confirmed in a Missouri resident who had no known contact with dairy cows, poultry or wild birds, US health officials report.

HealthDay News — Contraindicated drug pairs are uncommon in youth with Medicaid coverage filling combinations of behavioral and mental health (BMH) medications, according to a study published online ...

HealthDay News — An estimated 6.7% of US adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published online September 5 in ...

Researchers say the data indicate cancer cases continued to be underdiagnosed in the second year of the pandemic ...

Findings seen among patients with acute ischemic stroke treated with intravenous thrombolysis within three hours after symptom onset ...

The ultra-long acting investigational biologic is administered once every 6 months as a subcutaneous injection. Depemokimab reduced the rate of exacerbations in patients with severe asthma with type 2 ...

The randomized, double-blind, placebo-controlled phase 3 MATINEE study evaluated the safety and efficacy of mepolizumab in patients with COPD and type 2 inflammation.

HealthDay News — Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell carcinoma (ccRCC) and ...